Researcher eliminates viral vector in stem cell reprogramming

Shinya Yamanaka MD, PhD, of Kyoto University and the Gladstone Institute of Cardiovascular Disease (GICD) has taken another step forward in improving the possibilities for the practical application of induced pluripotent stem (iPS) cell technology.

If you want to include this story in your blog, copy and paste this formatted text: